Russian Sputnik 5 vaccine has 93% efficacy in successful trials

The race for the coronavirus has garnered momentum and the Russians have stepped up to the task. The Sputnik V vaccine has shown good potential against the infection 

Sputnik V shows immense promise against COVID-19 

The Russian coronavirus vaccine has been ascertained to provide about 93% protection against the virus, according to data released by the lancet. This vaccine has also shown promise to be safe and offer good protection against death and bed-ridden possibilities. 

The Russian vaccine has come under some intense criticism for being supplied ahead before the trial is completed. However, health officials have not confirmed that its efficiency is now guaranteed. Sputnik V has now joined proven vaccines like Moderna, AstraZeneca, Pfizer-BioNTech, and Janssen. 

Sputnik V works similarly to other vaccines but has different doses

Its workings are similar to the AstraZeneca vaccine created in the UK and Belgium Jansen vaccine. Sputnik uses a type of engineering harmless virus as a carrier to supply antibodies to the cells. By doing so, it exposes the body cells to the virus code which will defeat the virus before it could reach the body system. 

When this vaccine has been administered, the body will not start creating many antibodies specifically for the coronavirus. The aim of these is that the vaccinated person has a good immune system to deal with the virus. The Sputnik vaccine can be stored in temperatures ranging from 3 to 9 c degrees, which makes transportation easier and simple to store in modern fridges.

However, unlike other vaccines, it has a different jab for the first and second vaccination process which needs to be completed within three weeks apart. It is believed that using two diverse formulas as jabs makes your immune system better and will provide a sturdy protection layer. Side effects expected, includes mild headaches, sore hands, small tiredness, and warm temperatures. It has been used in Palestine, Uruguay, Argentina, Hungary, and Iran.